Physician profile
Travis B Redmon
NPI 1841552007
$950.62
in general payments reported to CMS, 2019-2025
10 companies · $34.83 in 2025
The $34.83 reported for 2025 was less than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $215 · 2021: $275 · 2022: $115 · 2023: $37.03 · 2024: $30.46 · 2025: $34.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $102.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $301.30 | 2019-2021 | |
| Csl Behring | $266.78 | 2019-2022 | |
| Allergan, INC. | $171.17 | 2019 | |
| Janssen Pharmaceuticals, INC | $108.99 | 2022-2024 | Xarelto |
| Inari Medical, INC. | $27.14 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $21.03 | 2025 | I-Stat |
| Portola Pharmaceuticals, LLC | $16.56 | 2019 | |
| Pfizer INC. | $13.80 | 2025 | |
| Merck Sharp & Dohme LLC | $12.11 | 2019 | |
| Chiesi USA, INC. | $11.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Redmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.